サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1472126

心房細動の世界市場規模調査＆予測、治療タイプ別、最終用途別、地域別分析、2023年～2030年

Global Atrial Fibrillation Market Size Study & Forecast, by Treatment Type (Pharmacological Treatment, Non-Pharmacological Treatment), By End-use (Hospitals, Specialty Clinics, Others), and Regional Analysis, 2023-2030

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.92円
心房細動の世界市場規模調査＆予測、治療タイプ別、最終用途別、地域別分析、2023年～2030年
出版日: 2024年04月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心房細動市場は2022年に約224億米ドルと評価され、予測期間2023-2030年には10.1%以上の健全な成長率で成長すると予測されています。

心房細動（AFib）は、不規則で速い心拍を特徴とする一般的な心臓リズム障害です。心房細動では、心臓の上室（心房）が下室（心室）と同期せずに無秩序に拍動するため、心拍が不規則になります。この不整脈により、体への血流が悪くなり、血栓、脳卒中、心不全、その他の心臓関連の合併症のリスクが高くなります。心房細動は時々起こるか、慢性化します。心房細動の症状には、動悸、胸痛、息切れ、疲労感、めまい、失神などがあります。心房細動の治療は、心拍を正常に戻し、心拍数をコントロールし、血栓を予防し、合併症のリスクを減らすことを目的としています。高齢化、座りがちなライフスタイル、肥満、心血管疾患の基礎疾患などの要因によって、心房細動の有病率が世界的に上昇していることが、市場成長の主な促進要因となっています。米国国立衛生研究所（NIH）によると、アジアでは心房細動の有病率は2050年までに7,200万人に急増すると予測されています。一方、National Institutes of Health（NIH）によれば、欧州では心房細動と診断された55歳以上の人口は2010年の900万人から2060年には1,790万人に増加すると予測されています。心房細動市場は、政府の取り組みやヘルスケア改革の増加、医療従事者や患者の心房細動に対する意識の高まり、診断技術の向上などの要因により拡大しています。

加えて、カテーテルアブレーションや左心房付属器閉鎖術（LAAC）など、心房細動治療のための低侵襲手技への傾斜が高まっていることも、世界全体の市場成長の触媒として作用しています。これらの手技は、従来の外科的アプローチと比較して、患者の回復時間が短く、合併症が少なく、治療成績が向上します。Statistaによると、世界の低侵襲手術市場は2019年に約205億米ドルを占めました。また、この金額は成長すると予測されており、2030年には約440億4,000万米ドルに達する可能性が高いです。したがって、これらの前述の要因は、推定期間中に心房細動市場の成長を推進しています。さらに、研究開発活動の増加や、社会的認知度を高めるためのプログラム数の増加は、予測期間中に様々な有利な機会を提示します。2022年1月、Peerbridge HealthはNorthwell Healthと提携し、心房細動（AFib）患者の治療を最適化することを目的とした共同イニシアチブであるAFib Center of Excellenceを立ち上げました。Peerbridgeの支援により、ノースウェルのAFib Center of Excellenceは、診断されていない閉塞性睡眠時無呼吸症候群（OSA）を有するAFib患者に焦点を当てたパイロットプログラムを開始します。このパイロットプログラムは、循環器科と睡眠科の医師の間で、この2つの疾患の重要な関連性と、心房細動とOSAの同時治療のための最も効果的な戦略についての理解を深めることを目的としています。このような心房細動治療薬の進歩は、市場の成長を促進すると予想されます。しかし、心房細動の処置やデバイスに関連する高額な費用や、デバイスに関連する規制の問題が、2023-2030年の予測期間を通じて市場成長の課題となっています。

世界の心房細動市場の調査で考慮した主な地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東＆アフリカです。北米は、心房細動の罹患率が上昇し、患者数が多いことから、2022年の市場を独占しました。主要な業界プレイヤーの存在は、この市場の優位性をさらに強化しています。米国疾病予防管理センター（CDC）によると、2019年には270万人から610万人の米国人が心房細動に罹患していると報告されており、2030年には推定1,210万人がこの疾患に罹患すると予測されています。一方、アジア太平洋地域は予測期間中最も高いCAGRで成長すると予想されています。同地域における心血管疾患と心房細動の有病率の上昇に加え、心臓治療の進歩を目指した研究開発への投資が増加しています。さらに、食事パターンの変化と座りがちなライフスタイルが、心血管疾患の急増に拍車をかけており、その結果、地域全体で効果的な治療ソリューションに対する需要が増加しています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 心房細動の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 心房細動の世界市場力学

  • 心房細動市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 政府のイニシアティブとヘルスケア改革の増加
      • 心房細動治療における低侵襲治療への志向の高まり
    • 市場の課題
      • 心房細動の処置とデバイスに関連する高コスト
      • デバイスに関連する規制上の問題
    • 市場機会
      • 研究開発活動の増加
      • 国民の意識を高めるためのプログラムの増加

第4章 世界の心房細動市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの提言・結論

第5章 心房細動の世界市場：治療タイプ別

  • 市場スナップショット
  • 心房細動の世界市場：治療タイプ別、実績 - ポテンシャル分析
  • 心房細動の世界市場：治療タイプ別推定・予測：2020年～2030年
  • 心房細動市場、サブセグメント別分析
    • 薬理学的治療
    • 非薬理学的治療

第6章 心房細動の世界市場：最終用途別

  • 市場スナップショット
  • 心房細動の世界市場：最終用途別、実績 - ポテンシャル分析
  • 心房細動の世界市場：最終用途別推定・予測、2020年～2030年
  • 心房細動市場、サブセグメント別分析
    • 病院
    • 専門クリニック
    • その他

第7章 心房細動の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 心房細動市場、地域別市場スナップショット
  • 北米
    • 米国
      • 治療タイプの推定・予測、2020年～2030年
      • 最終用途の推定・予測、2020年～2030年
    • カナダ
  • 欧州の心房細動市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の心房細動市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの心房細動市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東・アフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Boston Scientific Corporation
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Medtronic PLC
    • Biotronik SE & Co. KG
    • AtriCure Inc.
    • Cardiofocus Inc.
    • Abbott Laboratories
    • Johnson & Johnson
    • MicroPort Scientific Corporation
    • Koninklijke Philips NV
    • Siemens AG

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1.Global Atrial Fibrillation Market, report scope
  • TABLE 2.Global Atrial Fibrillation Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3.Global Atrial Fibrillation Market estimates & forecasts by Treatment Type 2020-2030 (USD Billion)
  • TABLE 4.Global Atrial Fibrillation Market estimates & forecasts by End-use 2020-2030 (USD Billion)
  • TABLE 5.Global Atrial Fibrillation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6.Global Atrial Fibrillation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7.Global Atrial Fibrillation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Atrial Fibrillation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Atrial Fibrillation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Atrial Fibrillation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Atrial Fibrillation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Atrial Fibrillation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Atrial Fibrillation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Atrial Fibrillation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.U.S. Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.U.S. Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17.U.S. Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18.Canada Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19.Canada Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20.Canada Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21.UK Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22.UK Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23.UK Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24.Germany Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25.Germany Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26.Germany Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27.France Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28.France Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29.France Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30.Italy Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31.Italy Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32.Italy Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33.Spain Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34.Spain Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35.Spain Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36.RoE Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37.RoE Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38.RoE Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39.China Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40.China Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41.China Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42.India Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43.India Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44.India Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45.Japan Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46.Japan Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47.Japan Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48.South Korea Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49.South Korea Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50.South Korea Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51.Australia Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52.Australia Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53.Australia Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54.RoAPAC Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55.RoAPAC Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57.Brazil Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58.Brazil Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59.Brazil Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60.Mexico Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61.Mexico Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62.Mexico Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63.RoLA Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64.RoLA Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65.RoLA Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66.Saudi Arabia Atrial Fibrillation Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67.South Africa Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68.RoMEA Atrial Fibrillation Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69.List of secondary sources, used in the study of global Atrial Fibrillation Market
  • TABLE 70.List of primary sources, used in the study of global Atrial Fibrillation Market
  • TABLE 71.Years considered for the study
  • TABLE 72.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Atrial Fibrillation Market, research methodology
  • FIG 2.Global Atrial Fibrillation Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Atrial Fibrillation Market, key trends 2022
  • FIG 5.Global Atrial Fibrillation Market, growth prospects 2023-2030
  • FIG 6.Global Atrial Fibrillation Market, porters 5 force model
  • FIG 7.Global Atrial Fibrillation Market, pest analysis
  • FIG 8.Global Atrial Fibrillation Market, value chain analysis
  • FIG 9.Global Atrial Fibrillation Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Atrial Fibrillation Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Atrial Fibrillation Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Atrial Fibrillation Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Atrial Fibrillation Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Atrial Fibrillation Market, regional snapshot 2020 & 2030
  • FIG 15.North America Atrial Fibrillation Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Atrial Fibrillation Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia Pacific Atrial Fibrillation Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Atrial Fibrillation Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Atrial Fibrillation Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Atrial Fibrillation Market is valued at approximately USD 22.4 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 10.1% over the forecast period 2023-2030. Atrial fibrillation (AFib) is a common heart rhythm disorder characterized by irregular and fast heartbeats. In AFib, the heart's upper chambers (atria) beat chaotically and out of sync with the lower chambers (ventricles), leading to an irregular heartbeat. This irregularity results in poor blood flow to the body, increasing the risk of complications such as blood clots, stroke, heart failure, and other heart-related complications. AFib occurs occasionally or becomes a chronic condition. Symptoms of AFib include palpitations, chest pain, shortness of breath, fatigue, dizziness, and fainting. Treatment for AFib aims to restore normal heart rhythm, control heart rate, prevent blood clots, and reduce the risk of complications. The rising prevalence of AFib globally, driven by factors such as ageing populations, sedentary lifestyles, obesity, and underlying cardiovascular conditions, is a major driver for market growth. According to the National Institutes of Health (NIH), in Asia, the prevalence of atrial fibrillation cases is forecasted to surge to 72 million by the year 2050. Meanwhile, the National Institutes of Health (NIH) stated that, in Europe, the population aged 55 and older diagnosed with atrial fibrillation is anticipated to rise from 9 million in 2010 to 17.9 million by the year 2060. The Atrial Fibrillation Market is expanding because of factors such as the increase in government initiatives and healthcare reforms, coupled with the increased awareness of AFib among healthcare professionals and patients, along with improved diagnostic techniques.

In addition, the rising inclination towards minimally invasive procedures for AFib treatment, such as catheter ablation and left atrial appendage closure (LAAC) is acting as a catalyzing factor for market growth across the globe. These procedures offer patients shorter recovery times, fewer complications, and improved outcomes compared to traditional surgical approaches. According to Statista, the minimally invasive surgery market worldwide accounted for nearly USD 20.5 billion in 2019. Also, the amount is projected to grow and is likely to reach around USD 44.04 billion by 2030. Thus, these aforementioned factors are propelling the growth of the Atrial Fibrillation Market during the estimated period. Moreover, the increasing research and development activities, as well as the rising number of programs to enhance public awareness present various lucrative opportunities over the forecast years. In January 2022, Peerbridge Health partnered with Northwell Health to launch the AFib Center of Excellence, a collaborative initiative aimed at optimizing treatment for patients with atrial fibrillation (AFib). With Peerbridge's support, Northwell's AFib Center of Excellence will initiate a pilot program focused on AFib patients with undiagnosed obstructive sleep apnea (OSA). The pilot program aims to enhance the understanding among cardiology and sleep physicians regarding the crucial link between the two conditions and the most effective strategies for concurrent treatment of AFib and OSA. These advancements in atrial fibrillation therapeutics are anticipated to propel market growth. However, the high costs associated with AFib procedures and devices, along with the regulatory issues associated with the devices are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Atrial Fibrillation Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the escalating incidence of atrial fibrillation and a substantial patient population in the region. The presence of key industry players further reinforces this market dominance. According to the Centers for Disease Control and Prevention (CDC), between 2.7 million and 6.1 million Americans were reported to have atrial fibrillation in 2019, with an estimated 12.1 million individuals projected to be affected by the condition by 2030. Whereas Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rise in the prevalence of cardiovascular diseases and atrial fibrillation in the region, along with growing investments in research and development aimed at advancing cardiac care. Additionally, shifting dietary patterns and sedentary lifestyles are fueling the surge in cardiovascular diseases resulting in increasing the demand for effective treatment solutions across the region, which, in turn, are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Boston Scientific Corporation
  • Medtronic PLC
  • Biotronik SE & Co. KG
  • AtriCure Inc.
  • Cardiofocus Inc.
  • Abbott Laboratories
  • Johnson & Johnson
  • MicroPort Scientific Corporation
  • Koninklijke Philips NV
  • Siemens AG

Recent Developments in the Market:

  • In February 2023, Abbott obtained approval from both the European Union and the US FDA for its TactiFlex Ablation Catheter and Sensor Enabled products. These cutting-edge ablation catheters incorporate a flexible tip and contact force sensing technology, specifically designed for treating abnormal heart rhythms, including atrial fibrillation. This initiative is likely contributed to advancements in AF treatment, enhanced competition and innovation in the market, improved patient outcomes, and expanded global access to cutting-edge technology for addressing abnormal heart rhythms.

Global Atrial Fibrillation Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Treatment Type, End-use, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

  • Pharmacological Treatment
  • Non-Pharmacological Treatment

By End-use:

  • Hospitals
  • Specialty Clinics
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Atrial Fibrillation Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2.Atrial Fibrillation Market, by Treatment Type, 2020-2030 (USD Billion)
    • 1.2.3.Atrial Fibrillation Market, by End-use, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Atrial Fibrillation Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Atrial Fibrillation Market Dynamics

  • 3.1.Atrial Fibrillation Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Increasing government initiatives and healthcare reforms
      • 3.1.1.2.Rising inclination towards minimally invasive procedures for AFib treatment
    • 3.1.2.Market Challenges
      • 3.1.2.1.High costs associated with AFib procedures and devices
      • 3.1.2.2.Regulatory issues associated with the devices
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Increasing research and development activities
      • 3.1.3.2.Growing number of programs to enhance public awareness

Chapter 4.Global Atrial Fibrillation Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Atrial Fibrillation Market, by Treatment Type

  • 5.1.Market Snapshot
  • 5.2.Global Atrial Fibrillation Market by Treatment Type, Performance - Potential Analysis
  • 5.3.Global Atrial Fibrillation Market Estimates & Forecasts by Treatment Type 2020-2030 (USD Billion)
  • 5.4.Atrial Fibrillation Market, Sub Segment Analysis
    • 5.4.1.Pharmacological Treatment
    • 5.4.2.Non-Pharmacological Treatment

Chapter 6.Global Atrial Fibrillation Market, by End-use

  • 6.1.Market Snapshot
  • 6.2.Global Atrial Fibrillation Market by End-use, Performance - Potential Analysis
  • 6.3.Global Atrial Fibrillation Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
  • 6.4.Atrial Fibrillation Market, Sub Segment Analysis
    • 6.4.1.Hospitals
    • 6.4.2.Specialty Clinics
    • 6.4.3.Others

Chapter 7.Global Atrial Fibrillation Market, Regional Analysis

  • 7.1.Top Leading Countries
  • 7.2.Top Emerging Countries
  • 7.3.Atrial Fibrillation Market, Regional Market Snapshot
  • 7.4.North America Atrial Fibrillation Market
    • 7.4.1.U.S. Atrial Fibrillation Market
      • 7.4.1.1.Treatment Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2.End-use breakdown estimates & forecasts, 2020-2030
    • 7.4.2.Canada Atrial Fibrillation Market
  • 7.5.Europe Atrial Fibrillation Market Snapshot
    • 7.5.1.U.K. Atrial Fibrillation Market
    • 7.5.2.Germany Atrial Fibrillation Market
    • 7.5.3.France Atrial Fibrillation Market
    • 7.5.4.Spain Atrial Fibrillation Market
    • 7.5.5.Italy Atrial Fibrillation Market
    • 7.5.6.Rest of Europe Atrial Fibrillation Market
  • 7.6.Asia-Pacific Atrial Fibrillation Market Snapshot
    • 7.6.1.China Atrial Fibrillation Market
    • 7.6.2.India Atrial Fibrillation Market
    • 7.6.3.Japan Atrial Fibrillation Market
    • 7.6.4.Australia Atrial Fibrillation Market
    • 7.6.5.South Korea Atrial Fibrillation Market
    • 7.6.6.Rest of Asia Pacific Atrial Fibrillation Market
  • 7.7.Latin America Atrial Fibrillation Market Snapshot
    • 7.7.1.Brazil Atrial Fibrillation Market
    • 7.7.2.Mexico Atrial Fibrillation Market
  • 7.8.Middle East & Africa Atrial Fibrillation Market
    • 7.8.1.Saudi Arabia Atrial Fibrillation Market
    • 7.8.2.South Africa Atrial Fibrillation Market
    • 7.8.3.Rest of Middle East & Africa Atrial Fibrillation Market

Chapter 8.Competitive Intelligence

  • 8.1.Key Company SWOT Analysis
  • 8.2.Top Market Strategies
  • 8.3.Company Profiles
    • 8.3.1. Boston Scientific Corporation
      • 8.3.1.1.Key Information
      • 8.3.1.2.Overview
      • 8.3.1.3.Financial (Subject to Data Availability)
      • 8.3.1.4.Product Summary
      • 8.3.1.5.Recent Developments
    • 8.3.2.Medtronic PLC
    • 8.3.3.Biotronik SE & Co. KG
    • 8.3.4.AtriCure Inc.
    • 8.3.5.Cardiofocus Inc.
    • 8.3.6.Abbott Laboratories
    • 8.3.7.Johnson & Johnson
    • 8.3.8.MicroPort Scientific Corporation
    • 8.3.9.Koninklijke Philips NV
    • 8.3.10.Siemens AG

Chapter 9.Research Process

  • 9.1.Research Process
    • 9.1.1.Data Mining
    • 9.1.2.Analysis
    • 9.1.3.Market Estimation
    • 9.1.4.Validation
    • 9.1.5.Publishing
  • 9.2.Research Attributes
  • 9.3.Research Assumption